Levothyroxine Sodium (Page 7 of 7)

PRINCIPAL DISPLAY PANEL — 88 mcg (0.088 mg)

NDC 42292-038-20

Levothyroxine
Sodium
Tablets, USP
88 mcg
(0.088 mg)

100 Tablets (10 x10)

Each tablet contains:
Levothyroxine
sodium, USP 88 mcg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from light and moisture.

U.S. Patent Nos. 6,645,526; 6,936,274;
7,052,717; 7,195,779

Manufactured by:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Rx only

S-12410

Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Levothyroxine Sodium 88 mcg (0.088 mg) Tablets Unit Carton Label
(click image for full-size original)
Serialized Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 112 mcg (0.112 mg)

NDC 42292-039-20

Levothyroxine
Sodium
Tablets, USP
112 mcg
(0.112 mg)

100 Tablets (10 x 10)

Each tablet contains:
Levothyroxine
sodium, USP 112 mcg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from light and moisture.

U.S. Patent Nos. 6,645,526; 6,936,274;
7,052,717; 7,195,779

Manufactured by:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Rx only

S-12413

Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Levothyroxine Sodium 112 mcg (0.112 mg) Tablets Unit Carton Label
(click image for full-size original)
Serialized Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 137 mcg (0.137 mg)

NDC 42292-041-20

Levothyroxine
Sodium
Tablets, USP
137 mcg
(0.137 mg)

100 Tablets (10 x 10)

Each tablet contains:
Levothyroxine
sodium, USP 137 mcg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from light and moisture.

U.S. Patent Nos. 6,645,526; 6,936,274;
7,052,717; 7,195,779

Manufactured by:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Rx only

S-12561

Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Levothyroxine Sodium 137 mcg (0.137 mg) Tablets Unit Carton Label
(click image for full-size original)
Serialized Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 175 mcg (0.175 mg)

NDC 42292-040-20

Levothyroxine
Sodium
Tablets, USP
175 mcg
(0.175 mg)

100 Tablets (10 x 10)

Each tablet contains:
Levothyroxine
sodium, USP 175 mcg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from light and moisture.

U.S. Patent Nos. 6,645,526; 6,936,274;
7,052,717; 7,195,779

Manufactured by:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Rx only

S-12414

Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Levothyroxine Sodium 175 mcg (0.175 mg) Tablets Unit Carton Label
(click image for full-size original)
Serialized Unit Carton
(click image for full-size original)
LEVOTHYROXINE SODIUM levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42292-038(NDC:0378-1807)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM ANHYDROUS 88 ug
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYANISOLE
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
MAGNESIUM STEARATE
MANNITOL
MICROCRYSTALLINE CELLULOSE
POVIDONE, UNSPECIFIED
SODIUM LAURYL SULFATE
SUCROSE
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C YELLOW NO. 6
Product Characteristics
Color green (olive) Score 2 pieces
Shape OVAL (capsule-shaped) Size 9mm
Flavor Imprint Code M;L;7
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42292-038-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (42292-038-01)
1 NDC:42292-038-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (42292-038-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076187 01/18/2017
LEVOTHYROXINE SODIUM levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42292-039(NDC:0378-1811)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM ANHYDROUS 112 ug
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYANISOLE
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
MAGNESIUM STEARATE
MANNITOL
MICROCRYSTALLINE CELLULOSE
POVIDONE, UNSPECIFIED
SODIUM LAURYL SULFATE
SUCROSE
D&C RED NO. 27
D&C RED NO. 30
Product Characteristics
Color pink (rose) Score 2 pieces
Shape OVAL (capsule-shaped) Size 9mm
Flavor Imprint Code M;L;9
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42292-039-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (42292-039-01)
1 NDC:42292-039-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (42292-039-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076187 01/19/2017
LEVOTHYROXINE SODIUM levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42292-041(NDC:0378-1823)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM ANHYDROUS 137 ug
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYANISOLE
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
MAGNESIUM STEARATE
MANNITOL
MICROCRYSTALLINE CELLULOSE
POVIDONE, UNSPECIFIED
SODIUM LAURYL SULFATE
SUCROSE
FD&C BLUE NO. 2
Product Characteristics
Color turquoise Score 2 pieces
Shape OVAL (capsule-shaped) Size 9mm
Flavor Imprint Code M;L;15
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42292-041-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (42292-041-01)
1 NDC:42292-041-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (42292-041-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076187 01/14/2019
LEVOTHYROXINE SODIUM levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42292-040(NDC:0378-1817)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM ANHYDROUS 175 ug
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYANISOLE
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
MAGNESIUM STEARATE
MANNITOL
MICROCRYSTALLINE CELLULOSE
POVIDONE, UNSPECIFIED
SODIUM LAURYL SULFATE
SUCROSE
D&C RED NO. 27
D&C RED NO. 30
FD&C BLUE NO. 1
Product Characteristics
Color purple (lilac) Score 2 pieces
Shape OVAL (capsule-shaped) Size 9mm
Flavor Imprint Code M;L;12
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42292-040-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (42292-040-01)
1 NDC:42292-040-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (42292-040-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076187 01/19/2017
Labeler — Mylan Institutional Inc. (039615992)

Revised: 01/2019 Mylan Institutional Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.